Literature DB >> 19029136

Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes.

Gui-Rong Li1, Hai-Ying Sun, Xiao-Hua Zhang, Lik-Cheung Cheng, Shui-Wah Chiu, Hung-Fat Tse, Chu-Pak Lau.   

Abstract

AIMS: The omega-3 (n-3) polyunsaturated fatty acids (omega-3 PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from fish oil were recently reported to have an anti-atrial fibrillation effect in humans; however, the ionic mechanisms of this effect are not fully understood. The present study was designed to determine the effects of EPA and DHA on transient outward and ultra-rapid delayed rectifier potassium currents (I(to) and I(Kur)) and the voltage-gated sodium current (I(Na)) in human atrial myocytes. METHODS AND
RESULTS: A whole-cell patch voltage clamp technique was employed to record I(to) and I(Kur), and I(Na) in human atrial myocytes. It was found that EPA and DHA inhibited I(to) in a concentration-dependent manner (IC(50): 6.2 microM for EPA; 4.1 microM for DHA) and positively shifted voltage-dependent activation of the current. In addition, I(Kur) was suppressed by 1-50 microM EPA (IC(50): 17.5 microM) and DHA (IC(50): 4.3 microM). Moreover, EPA and DHA reduced I(Na) in human atrial myocytes in a concentration-dependent manner (IC(50): 10.8 microM for EPA; 41.2 microM for DHA) and negatively shifted the potential of I(Na) availability. The I(Na) block by EPA or DHA was use-independent.
CONCLUSION: The present study demonstrates for the first time that EPA and DHA inhibit human atrial I(to), I(Kur), and I(Na) in a concentration-dependent manner; these effects may contribute, at least in part, to the anti-atrial fibrillation of omega-3 PUFAs in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029136     DOI: 10.1093/cvr/cvn322

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  36 in total

1.  Eicosapentaenoic acid for the prevention of recurrent atrial fibrillation.

Authors:  Eiichi Watanabe; Yoshihiro Sobue; Kan Sano; Kentarou Okuda; Mayumi Yamamoto; Yukio Ozaki
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-10       Impact factor: 1.468

Review 2.  (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?

Authors:  Dariush Mozaffarian; Jason H Y Wu
Journal:  J Nutr       Date:  2012-01-25       Impact factor: 4.798

3.  Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study.

Authors:  Jason H Y Wu; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Frank M Sacks; Eric B Rimm; Susan R Heckbert; David S Siscovick; Dariush Mozaffarian
Journal:  Circulation       Date:  2012-01-26       Impact factor: 29.690

Review 4.  n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: Principles, Practices, Pitfalls, and Promises - A Contemporary Review.

Authors:  Richard Kones; Scott Howell; Umme Rumana
Journal:  Med Princ Pract       Date:  2017-11-29       Impact factor: 1.927

Review 5.  Novel pharmacological targets for the rhythm control management of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2011-08-17       Impact factor: 12.310

6.  A distinct de novo expression of Nav1.5 sodium channels in human atrial fibroblasts differentiated into myofibroblasts.

Authors:  Aurélien Chatelier; Aurélie Mercier; Boris Tremblier; Olivier Thériault; Majed Moubarak; Najate Benamer; Pierre Corbi; Patrick Bois; Mohamed Chahine; Jean François Faivre
Journal:  J Physiol       Date:  2012-07-16       Impact factor: 5.182

7.  Coupled left-shift of Nav channels: modeling the Na⁺-loading and dysfunctional excitability of damaged axons.

Authors:  Pierre-Alexandre Boucher; Béla Joós; Catherine E Morris
Journal:  J Comput Neurosci       Date:  2012-04-05       Impact factor: 1.621

8.  SKF-96365 strongly inhibits voltage-gated sodium current in rat ventricular myocytes.

Authors:  Kui-Hao Chen; Hui Liu; Lei Yang; Man-Wen Jin; Gui-Rong Li
Journal:  Pflugers Arch       Date:  2014-07-15       Impact factor: 3.657

Review 9.  Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance.

Authors:  Irene Savelieva; Antonios Kourliouros; John Camm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-25       Impact factor: 3.000

Review 10.  Omega-3 PUFAs and atrial fibrillation: have we made up our mind yet?

Authors:  Federico Guerra; Matilda Shkoza; Lorena Scappini; Laura Roberti; Alessandro Capucci
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.